An additive/substractive genotypic score as a determinant of the virological response to didanosine in HIV-1 infected patients

Taking into account the mutations associated with a better VR may improve genotypic resistance algorithms. Our results are of interest for the management of antiretroviral therapy in NRTI-experienced patients.